In addition, by applying two epigenetic modulators including the HDAC inhibitor, TSA and the demethylation agent, 5-aza, we were able to investigate the epigenetic mechanisms of ERα-reactivation and to explore the applicability of this or similar combination to breast cancer therapy. This evidence concerns the gene ESR1 and breast cancer.